Categories Earnings, Health Care
Bausch Health Companies Inc. (NYSE: BHC): Q4 2019 Earnings Snapshot
— Bausch Health Companies Inc. (NYSE: BHC) reported a loss of $4.30 per share for the fourth quarter of 2019, compared to a loss of $0.98 per share last year, vs. $1.15 per share loss expected.
— Net loss for the quarter was $1.516 billion, compared to a loss of $344 million a year earlier
— December-quarter revenues increased 5% annually to $2.22 billion, vs. $2.2 billion expected
— Revenue of Bausch + Lomb/International, the main business segment, grew 3% annually; Salix segment revenue was up 21%
— Received FDA approval for ARAZLO Lotion for the topical treatment of acne vulgaris in young adults
— Raised capital allocation for research and development by 14% in fiscal 2019, compared to last year
— Expects full-year 2020 revenues to be in the range of $8.65 billion to $8.85 billion
— Looking for adjusted EBITDA in the range of $3.50 billion to $3.65 billion for fiscal 2020
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%